Mirati Therapeutics, Inc.·4

Jan 3, 6:27 PM ET

Gallagher Carol Giltner 4

4 · Mirati Therapeutics, Inc. · Filed Jan 3, 2024

Insider Transaction Report

Form 4
Period: 2023-12-29
Transactions
  • Award

    Common Stock

    2023-12-29$58.75/sh+6,808$399,97014,363 total
Footnotes (1)
  • [F1]Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the anniversary of the grant date.

Documents

1 file
  • 4
    wk-form4_1704324430.xmlPrimary

    FORM 4